tiprankstipranks
Advertisement
Advertisement

LGVN Stock Latest News

Longeveron Restores Nasdaq Compliance with New Audit Committee
Company AnnouncementsLongeveron Restores Nasdaq Compliance with New Audit Committee
8d ago
8K
LGVN
Longeveron Enhances CEO Compensation and Retention Protections
PremiumCompany Announcements
Longeveron Enhances CEO Compensation and Retention Protections
22d ago
8K
LGVN
Longeveron presents positive laromestrocel data in Alzheimer’s disease
PremiumThe Fly
Longeveron presents positive laromestrocel data in Alzheimer’s disease
24d ago
LGVN
Longeveron grants special equity awards to Executive Chairman
PremiumCompany Announcements
Longeveron grants special equity awards to Executive Chairman
29d ago
8K
LGVN
Longeveron strengthens financial leadership with new CFO appointment
PremiumCompany Announcements
Longeveron strengthens financial leadership with new CFO appointment
1M ago
8K
LGVN
Longeveron appoints Marie Washburn CFO
PremiumThe FlyLongeveron appoints Marie Washburn CFO
1M ago
LGVN
Longeveron granted SME status by European Medicines Agency
Premium
The Fly
Longeveron granted SME status by European Medicines Agency
2M ago
LGVN
Longeveron Announces CFO Transition to Internal Successor
Premium
Company Announcements
Longeveron Announces CFO Transition to Internal Successor
2M ago
8K
LGVN
Longeveron Earnings Call: Trial Milestones Amid FDA Hurdles
PremiumCompany Announcements
Longeveron Earnings Call: Trial Milestones Amid FDA Hurdles
3M ago
LGVN
Longeveron reports Q1 EPS (19c) vs. (34c) last year
PremiumThe Fly
Longeveron reports Q1 EPS (19c) vs. (34c) last year
3M ago
LGVN
Longeveron reports DMC approval for laromestrocel study to continue as designed
PremiumThe Fly
Longeveron reports DMC approval for laromestrocel study to continue as designed
3M ago
LGVN
Longeveron downgraded to Hold from Buy at Maxim
PremiumThe Fly
Longeveron downgraded to Hold from Buy at Maxim
3M ago
LGVN
Is LGVN a Buy, Before Earnings?
PremiumPre-EarningsIs LGVN a Buy, Before Earnings?
3M ago
LGVN
Longeveron provides update on laromestrocel development after Type C meeting
Premium
The Fly
Longeveron provides update on laromestrocel development after Type C meeting
3M ago
LGVN
Longeveron Updates FDA Path for ELPIS II Trial
Premium
Company Announcements
Longeveron Updates FDA Path for ELPIS II Trial
3M ago
8K
LGVN
Longeveron price target lowered to $8 from $10 at H.C. Wainwright
PremiumThe Fly
Longeveron price target lowered to $8 from $10 at H.C. Wainwright
3M ago
LGVN
Longeveron Restores Executive Pay After Recent Financing
PremiumCompany Announcements
Longeveron Restores Executive Pay After Recent Financing
4M ago
8K
LGVN
Longeveron files to sell 30.87M shares of Class A common stock for holders
PremiumThe Fly
Longeveron files to sell 30.87M shares of Class A common stock for holders
4M ago
LGVN
Longeveron granted Chinese patent for potency assay methods
PremiumThe Fly
Longeveron granted Chinese patent for potency assay methods
4M ago
LGVN
Longeveron granted Chinese patent for potency assay methods
PremiumThe FlyLongeveron granted Chinese patent for potency assay methods
4M ago
LGVN
Longeveron Receives Extended Nasdaq Compliance Grace Period
Premium
Company Announcements
Longeveron Receives Extended Nasdaq Compliance Grace Period
4M ago
8K
LGVN
Longeveron Cancels Special Meeting, Reschedules Reverse Split Vote
Premium
Company Announcements
Longeveron Cancels Special Meeting, Reschedules Reverse Split Vote
4M ago
8K
LGVN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >